Dignitana

Dignitana

Clinically superior scalp cooling to minimize hair loss from chemotherapy - FDA cleared since 2015

Founded 1996

Dallas, United States 33 employees Post-IPO Equity Total: $25.00M Health Care

Dignitana is a Swedish medical device company that produces The DigniCap Scalp Cooling System, a patented and FDA cleared medical cooling device that improves quality of life for cancer patients by minimizing hair loss from chemotherapy. Since its founding in 1996, Dignitana has been dedicated to providing clinically superior scalp cooling with its innovative technology. The company’s continuous cooling with high efficacy, safety, and patient comfort has been well received in the industry. Dignitana is publicly traded on Nasdaq First North Growth Market, with headquarters in Lund, Sweden and operations based in Dallas, Texas. The most recent investment worth kr25.00MPost-IPO Equity was injected into the company on 18 October 2022. The investors contributing to this growth include Handelsbanken, Swedbank Robur, and Agartha. This investment serves as an indication of the confidence that established financial institutions have in Dignitana's capability to offer valuable and high-quality solutions in the healthcare industry. As Dignitana continues to make strides in providing essential support to cancer patients, its ability to attract significant post-IPO equity investments signifies a promising future for the company.

Funding Stage	Amount	Investors	Lead Investors	Date
Post IPO Equity	kr25.00M	3	Swedbank Robur, Handelsbanken +1	18 Oct 2022

Funding Stage

Amount

Investors

Lead Investors

Date

Post IPO Equity

kr25.00M

Swedbank Robur, Handelsbanken +1

18 Oct 2022

FAQ About Dignitana

Clinically superior scalp cooling to minimize hair loss from chemotherapy - FDA cleared since 2015

Dignitana was founded in 1996.

Dignitana is headquartered in Dallas, United States.

Dignitana operates in Health Care. Its work centres on Medical Device, Scalp Cooling, Cancer Care and Chemotherapy.

Dignitana has approximately 33 employees.

Dignitana has completed 1 funding round, raising a total of $25.00M. The latest funding stage is Post-IPO Equity.

Top alternatives and competitors to Dignitana include Hairguard, Luminate, Agennix, OtoSet® by SafKan Health, Neocis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Dignitana and Hairguard are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Dignitana

Funding Rounds & Investors (1)

Dignitana Alternatives & Competitors

FAQ About Dignitana